How Is Histone Butyrylation Linked to Short-Chain Fatty Acid Metabolism?

With the rapid advancement of epigenetics, histone post-translational modifications (PTMs) have emerged as a central avenue for elucidating mechanisms of gene expression regulation. In recent years, histone butyrylation (Kbu), an emerging type of acylation modification, has attracted increasing attention in the life sciences. Concurrently, short-chain fatty acids (SCFAs), key metabolites produced by the gut microbiota, are increasingly recognized for their roles in host metabolism and epigenetic regulation.

What Is Histone Butyrylation?

Histone butyrylation is an acylation modification occurring on lysine residues. Structurally similar to acetylation, it involves the addition of a butyryl group (-CO-C3H7). This modification was first identified using high-resolution mass spectrometry and is considered an important member of non-classical histone modifications.

Characteristics of Butyrylation

• Derived from intracellular butyryl-CoA

• Predominantly occurs on core histones such as H3 and H4

• Closely associated with open chromatin states and transcriptional activation

Compared with acetylation, butyrylation possesses a longer carbon chain, which may induce distinct steric effects during chromatin remodeling, thereby influencing protein-DNA interactions.

Short-Chain Fatty Acids: A Bridge Between Metabolism and Epigenetics

1. Major Types of Short-Chain Fatty Acids

• Acetate

• Propionate

• Butyrate

These metabolites are primarily generated through microbial fermentation of dietary fiber in the gut. They serve not only as key energy sources for the host but also as important signaling molecules.

2. Biological Functions of Butyrate

Butyrate serves as the primary energy source for colonic epithelial cells and exerts multiple biological functions:

• Inhibition of histone deacetylases (HDACs)

• Regulation of immune responses

• Maintenance of intestinal barrier integrity

• Modulation of gene expression

Importantly, butyrate can be converted intracellularly into butyryl-CoA, which directly serves as a substrate for histone butyrylation.

Molecular Mechanisms Linking Histone Butyrylation and SCFA Metabolism

1. Butyrate-Driven Substrate Supply for Butyrylation

Upon cellular uptake, butyrate contributes to histone butyrylation through the following processes:

• Conversion into butyryl-CoA

• Utilization of butyryl-CoA as a substrate by histone acyltransferases (e.g., p300)

• Deposition of butyryl groups on lysine residues

This pathway exemplifies the direct regulation of epigenetic modifications by metabolic intermediates.

2. Dual Regulatory Roles of Butyrate

Butyrate exerts dual functions in the regulation of histone modifications:

(1) As a Substrate Promoting Butyrylation

• Providing a source of butyryl groups

• Enhancing Kbu levels at specific genomic loci

(2) As an HDAC Inhibitor

• Suppressing deacetylase activity

• Indirectly elevating levels of both acetylation and butyrylation

These dual roles position butyrate as a critical hub linking cellular metabolism and chromatin regulation.

3. Competition and Coordination Between Butyrylation and Acetylation

Because butyrylation and acetylation share common enzymatic machinery (e.g., p300/CBP), competitive interactions may arise:

• Elevated butyrate levels may favor butyrylation over acetylation.

• Distinct modifications exert differential effects on transcriptional activation.

• Chromatin regulation is thereby fine-tuned at multiple levels.

Roles of Histone Butyrylation in Physiology and Disease

1. Intestinal Homeostasis and Inflammation

Butyrate-mediated histone butyrylation plays a critical role in intestinal biology:

• Regulation of anti-inflammatory gene expression

• Inhibition of the NF-κB signaling pathway

• Maintenance of intestinal immune homeostasis

In patients with inflammatory bowel disease (IBD), reduced butyrate levels are often associated with aberrant butyrylation patterns.

2. Roles in Cancer

In oncology, histone butyrylation exhibits context-dependent regulatory effects:

• Promotion of tumor suppressor gene expression under certain conditions

• Contribution to cancer cell adaptation during metabolic reprogramming

For instance, in colorectal cancer, butyrate can inhibit tumor cell proliferation while, under specific conditions, promoting tumor growth (the "butyrate paradox").

3. Metabolic Disorders

Dysregulation of SCFA metabolism is closely associated with:

• Obesity

• Type 2 diabetes

• Non-alcoholic fatty liver disease (NAFLD)

As a molecular readout of metabolic states, histone butyrylation may play a pivotal regulatory role in these conditions.

Technical Challenges and Solutions in Studying Histone Butyrylation

Despite its promise, the study of histone butyrylation faces several analytical challenges:

1. Technical Challenges

• Low abundance of modification

• Limited antibody specificity

• Coexistence of multiple acylation modifications complicating discrimination

2. Central Role of Mass Spectrometry

High-resolution liquid chromatography-tandem mass spectrometry (LC-MS/MS) serves as the core analytical platform:

• Precise identification of modification sites

• Quantitative profiling of dynamic changes

• Discrimination among acylation types (e.g., acetylation, butyrylation, propionylation)

Optimization of sample preparation workflows (e.g., histone enrichment and proteolytic digestion strategies) and data analysis pipelines can substantially improve detection sensitivity and accuracy.

Future Perspectives

Research on histone butyrylation and SCFA metabolism remains in a phase of rapid expansion. Key future directions include:

• Mapping butyrylation landscapes across different tissues

• Identification of butyrylation writer/eraser/reader proteins

• Systematic investigation of the microbiome-metabolite-epigenetic axis

• Development of single-cell resolution butyrylation analyses